Additional direct medical costs of nosocomial infections: an estimation from a cohort of patients in a French university hospital

Journal of Hospital Infection

Volumn 68, Issue 2, 2008, Pages 130-136

  Defez, C ^a   Fabbro Peray, P ^a,b   Cazaban, M ^a,b   Boudemaghe, T ^a   Sotto, A ^a,c   Daures J P ^a,b  

^a DEPARTMENT OF NEUROLOGY   (France)

^b UNIV MONTPELLIER   (France)

^c INSERM   (France)

Author keywords

Hospital acquired infection; Medical cost

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST OF ILLNESS; DISEASE SEVERITY; DRUG COST; ECONOMIC EVALUATION; FEMALE; FRANCE; GASTROINTESTINAL INFECTION; HEALTH CARE COST; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; LABORATORY TEST; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RADIOGRAPHY; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION; THORAX SURGERY; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; URINARY TRACT SURGERY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS INFECTION; DIAGNOSIS-RELATED GROUPS; FEMALE; FRANCE; HEALTH CARE COSTS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 39049087529     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2007.11.005     Document Type: Article

References (26)

1. Haley R.W., Hooton T.M., Culver D.H., et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med 70 (1981) 947-959
2. Stone P.W., Larson E., and Kawar L.N. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 30 (2002) 145-152
3. Haley R.W., Culver D.H., White J.W., Morgan W.M., and Emori T.G. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 121 (1985) 159-167
4. Astagneau P., Fleury L., Leroy S., et al. Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. J Hosp Infect 42 (1999) 303-312
5. Kaoutar B., Joly C., L'Heriteau F., et al. Nosocomial infections and hospital mortality: a multicentre epidemiology study. J Hosp Infect 58 (2004) 268-275
6. Allenet B. Impact économique et de santé publique des infections nosocomiales. Inter bloc XIX (2000) 141-144
7. Mahieu L.M., Buitenweg N., Beutels P., and De Dooy J.J. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect 47 (2001) 223-229
8. Dietrich E.S., Demmler M., Schulgen G., et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection 30 (2002) 61-67
9. Digiovine B., Chenoweth C., Watts C., and Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160 (1999) 976-981
10. Pittet D., Tarara D., and Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. J Am Med Assoc 271 (1994) 1598-1601
11. Whitehouse J.D., Friedman N.D., Kirkland K.B., Richardson W.J., and Sexton D.J. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 23 (2002) 183-189
12. Chaix C., Durand-Zaleski I., Alberti C., and Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. J Am Med Assoc 282 (1999) 1745-1751
13. Fabbro-Peray P., Sotto A., Defez C., et al. Mortality attributable to nosocomial infection: an exposed-non-exposed cohort of patients in a French University Hospital. Infect Control Hosp Epidemiol 28 (2007) 265-272
14. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
15. McCabe W., and Jackson G. Gram-negative bacteremia. Arch Intern Med 110 (1962) 847-855
16. Plowman R., Graves N., Griffin M.A., et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 47 (2001) 198-209
17. Lauria F.N., and Angeletti C. The impact of nosocomial infections on hospital care costs. Infection 31 Suppl. 2 (2003) 35-43
18. Goossens M.E., Rutten-van Molken M.P., Vlaeyen J.W., and van der Linden S.M. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 53 (2000) 688-695
19. Durand-Zaleski I. Le coût des infections liées aux soins. Actualités et dossiers en santé publique (2002) 29-31
20. Charvet-Protat S. Medico-economic analysis of nosocomial infections. Presse Med 29 (2000) 1782-1787
21. Haley R.W., Culver D.H., White J.W., et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121 (1985) 182-205
22. French G.L., and Cheng A.F. Measurement of the costs of hospital infection by prevalence surveys. J Hosp Infect 18 Suppl. A (1991) 65-72
23. Wakefield D.S., Helms C.M., Massanari R.M., Mori M., and Pfaller M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 16 (1988) 185-192
24. Vegni F.E., Panceri M.L., Biffi M., Banfi E., Porretta A.D., and Privitera G. Three scenarios of clinical claim reimbursement for nosocomial infection: the good, the bad, and the ugly. J Hosp Infect 56 (2004) 150-155
25. Obasanjo O., and Perl T.M. Cost-benefit and effectiveness of nosocomial surveillance methods. Curr Clin Top Infect Dis 21 (2001) 391-406
26. Massanari R.M., Wilkerson K., Streed S.A., and Hierholzer Jr. W.J. Reliability of reporting nosocomial infections in the discharge abstract and implications for receipt of revenues under prospective reimbursement. Am J Public Health 77 (1987) 561-564